Clinical Trial Update: Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating the combination of topotecan and paclitaxel in patients with advanced non-small cell lung cancer and other advanced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Taxol (paclitaxel)
• Topotecan (topotecan)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Unspecified Adult Solid Tumor, Protocol Specific | Phase 1, Phase 2 | Status: COMPLETED